| Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat A Seluanov, C Hine, J Azpurua, M Feigenson, M Bozzella, Z Mao, ... Proceedings of the National Academy of Sciences 106 (46), 19352-19357, 2009 | 457 | 2009 |
| The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers S Efrati, M Averbukh, V Dishy, M Faygenzo, L Friedensohn, A Golik European journal of clinical pharmacology 63, 113-121, 2007 | 64 | 2007 |
| The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism R Koren Peleg, S Efrati, C Benbassat, M Fygenzo, A Golik Thyroid 18 (8), 825-830, 2008 | 55 | 2008 |
| Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients. S Efrati, N Gall, J Bergan, G Fishlev, A Bass, S Berman, R Abu-Hamad, ... Undersea & Hyperbaric Medicine 36 (1), 1, 2009 | 44 | 2009 |
| The Role of Bmp2 in the Maturation and Maintenance of the Murine Knee Joint LW Gamer, S Pregizer, J Gamer, M Feigenson, A Ionescu, Q Li, L Han, ... Journal of Bone and Mineral Research 33 (9), 1708-1717, 2018 | 37 | 2018 |
| Histone deacetylase 3 deletion in mesenchymal progenitor cells hinders long bone development M Feigenson, LC Shull, EL Taylor, ET Camilleri, SM Riester, ... Journal of Bone and Mineral Research 32 (12), 2453-2465, 2017 | 32 | 2017 |
| Reactivation of a developmental Bmp2 signaling center is required for therapeutic control of the murine periosteal niche VS Salazar, LP Capelo, C Cantù, D Zimmerli, N Gosalia, S Pregizer, ... Elife 8, e42386, 2019 | 30 | 2019 |
| PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy Metabolism M Feigenson, RA Eliseev, JH Jonason, BN Mills, RJ O'Keefe Journal of Cellular biochemistry, 2017 | 25 | 2017 |
| Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis SM Hwang, M Feigenson, DL Begun, LC Shull, KL Culley, M Otero, ... Journal of Orthopaedic Research® 36 (5), 1487-1497, 2018 | 21 | 2018 |
| Carotid atherosclerotic disease following childhood scalp irradiation E Shai, S Siegal, Z Michael, K Itzhak, R Ronen, M Dror, B Sylvia, ... Atherosclerosis 204 (2), 556-560, 2009 | 21 | 2009 |
| Loss of the PGE2 receptor EP1 enhances bone acquisition, which protects against age and ovariectomy-induced impairments in bone strength M Zhang, M Feigenson, T Sheu, HA Awad, EM Schwarz, JH Jonason, ... Bone 72, 92-100, 2015 | 20 | 2015 |
| Inhibition of the prostaglandin EP-1 receptor in periosteum progenitor cells enhances osteoblast differentiation and fracture repair M Feigenson, JH Jonason, J Shen, AE Loiselle, HA Awad, RJ O’Keefe Annals of biomedical engineering 48, 927-939, 2020 | 9 | 2020 |
| Ker-050, a novel inhibitor of Tgfβ superfamily signaling, induces red blood cell production by promoting multiple stages of erythroid differentiation M Feigenson, R Nathan, C Materna, A Gudelsky, E Lema, CC Tseng, ... Blood 136, 34, 2020 | 7 | 2020 |
| Transverse fracture of the mouse femur with stabilizing pin ER Moore, M Feigenson, DE Maridas JoVE (Journal of Visualized Experiments), e63074, 2021 | 4 | 2021 |
| KER-050, a modified ActRIIA ligand trap, alleviates cytopenia arising from multiple etiologies M Feigenson, R Nathan, K Babbs, C Materna, CC Tseng, F Fisher, ... Blood 136, 38, 2020 | 2 | 2020 |
| Ker-050, an inhibitor of TGF-β superfamily signaling, promoted thrombopoiesis and reversed immune thrombocytopenia in a mouse model of disease M Feigenson, R Nathan, J Lamora, F Fisher, CC Tseng, J Seehra, ... Blood 138, 2068, 2021 | 1 | 2021 |
| Bone morphogenetic proteins DE Maridas, M Feigenson, NE Renthal, SM Chim, LW Gamer, V Rosen Principles of Bone Biology, 1189-1197, 2020 | 1 | 2020 |
| Rker-050 Rescued Ruxolitinib (Rux)-Associated Reductions in Red Blood Cell Volume R Nathan, M Feigenson, J Lamora, CC Tseng, F Fisher, J Seehra, ... Blood 138, 934, 2021 | | 2021 |
| Author response: Reactivation of a developmental Bmp2 signaling center is required for therapeutic control of the murine periosteal niche VS Salazar, LP Capelo, C Cantù, D Zimmerli, N Gosalia, S Pregizer, ... | | |
